140 related articles for article (PubMed ID: 891100)
1. Effects of hexachlorobenzene feeding and iron overload on enzymes of haem biosynthesis and cytochrome P 450 in rat liver.
Louw M; Neethling AC; Percy VA; Carstens M; Shanley BC
Clin Sci Mol Med; 1977 Aug; 53(2):111-5. PubMed ID: 891100
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of hexachlorobenzene-induced porphyria in rats. Effect of phenobarbitone pretreatment.
Wainstok de Calmanovici R; Ríos de Molina MC; Taira de Yamasato MC; Tomio JM; San Martin de Viale LC
Biochem J; 1984 Mar; 218(3):753-63. PubMed ID: 6721832
[TBL] [Abstract][Full Text] [Related]
3. A difference between two strains of rats in their liver non-haem iron content and in their response to the porphyrogenic effect of hexachlorobenzene.
Smith AG; Cabral JR; De Matteis F
Chem Biol Interact; 1979 Oct; 27(2-3):353-63. PubMed ID: 498361
[TBL] [Abstract][Full Text] [Related]
4. Hepatocarcinogenicity of hexachlorobenzene in rats and the sex difference in hepatic iron status and development of porphyria.
Smith AG; Francis JE; Dinsdale D; Manson MM; Cabral JR
Carcinogenesis; 1985 Apr; 6(4):631-6. PubMed ID: 3986965
[TBL] [Abstract][Full Text] [Related]
5. Mechanistic studies of the inhibition of hepatic uroporphyrinogen decarboxylase in C57BL/10 mice by iron-hexachlorobenzene synergism.
Smith AG; Francis JE; Kay SJ; Greig JB; Stewart FP
Biochem J; 1986 Sep; 238(3):871-8. PubMed ID: 3800966
[TBL] [Abstract][Full Text] [Related]
6. The effects of ethanol, estrogen, and hexachlorobenzene on the activities of hepatic delta-aminolevulinate synthetase, delta-aminolevulinate dehydratase, and uroporphyrinogen decarboxylase in male rats.
Kondo M; Shimizu Y
Arch Toxicol; 1986 Oct; 59(3):141-5. PubMed ID: 3813879
[TBL] [Abstract][Full Text] [Related]
7. Immunochemical studies of the uroporphyrinogen decarboxylase defect caused by hexachlorobenzene.
Elder GH; Urquhart AJ
IARC Sci Publ; 1986; (77):441-8. PubMed ID: 3596736
[TBL] [Abstract][Full Text] [Related]
8. The effect of the porphyrogenic compound, hexachlorobenzene, on the activity of hepatic uroporphyrinogen decarboxylase in the rat.
Elder GH; Evans JO; Matlin SA
Clin Sci Mol Med; 1976 Jul; 51(1):71-80. PubMed ID: 939068
[TBL] [Abstract][Full Text] [Related]
9. Development of hexachlorobenzene porphyria in rats: time sequence and relationship with lipid peroxidation.
Visser O; van den Berg JW; Edixhoven-Bosdijk A; Koole-Lesuis R; Rietveld T; Wilson JH
Food Chem Toxicol; 1989 May; 27(5):317-21. PubMed ID: 2744662
[TBL] [Abstract][Full Text] [Related]
10. The decrease in uroporphyrinogen decarboxylase activity induced by ethanol predisposes rats to the development of porphyria and accelerates xenobiotic-triggered porphyria, regardless of hepatic damage.
Ríos de Molina MC; Mazzetti MB; Galigniana M; Aldonatti C; Tomio JM; San Martín de Viale LC
Braz J Med Biol Res; 2002 Nov; 35(11):1273-83. PubMed ID: 12426626
[TBL] [Abstract][Full Text] [Related]
11. Influence of N-acetylcysteine on the hexachlorobenzene induced porphyria in rats.
Lissner R; Brunner W; Bolsen K; Merk H; Goerz G
Arzneimittelforschung; 1985; 35(4):713-5. PubMed ID: 4015737
[TBL] [Abstract][Full Text] [Related]
12. The involvement of iron and lipid peroxidation in the pathogenesis of HCB induced porphyria.
Alleman MA; Koster JF; Wilson JH; Edixhoven-Bosdijk A; Slee RG; Kroos MJ; von Eijk HG
Biochem Pharmacol; 1985 Jan; 34(2):161-6. PubMed ID: 3966921
[TBL] [Abstract][Full Text] [Related]
13. Relative abilities on a molar basis of hexafluoro-, hexachloro- and hexabromobenzenes to decrease liver uroporphyrinogen decarboxylase activity and cause porphyria in female rats.
Smith AG; Francis JE
Res Commun Chem Pathol Pharmacol; 1980 May; 28(2):377-84. PubMed ID: 7394329
[TBL] [Abstract][Full Text] [Related]
14. The treatment of acute intermittent porphyria with laevulose.
Brodie MJ; Moore MR; Thompson GG; Goldberg A
Clin Sci Mol Med; 1977 Oct; 53(4):365-71. PubMed ID: 913061
[TBL] [Abstract][Full Text] [Related]
15. Heme metabolism after discontinued hexachlorobenzene administration in rats: possible irreversible changes and biomarker for hexachlorobenzene persistence.
De Catabbi SCB ; Aldonatti C; de Viale LC
Comp Biochem Physiol C Toxicol Pharmacol; 2000 Sep; 127(2):165-75. PubMed ID: 11083027
[TBL] [Abstract][Full Text] [Related]
16. Studies on the toxicology of hexachlorobenzene. V. Different phases of porphyria during and after treatment.
Koss G; Seubert S; Seubert A; Seidel J; Koransky W; Ippen H
Arch Toxicol; 1983 Jan; 52(1):13-22. PubMed ID: 6838374
[No Abstract] [Full Text] [Related]
17. Thyroid function and thyroxine metabolism in hexachlorobenzene-induced porphyria.
Kleiman de Pisarev DL; Rios de Molina MC; San Martin de Viale LC
Biochem Pharmacol; 1990 Mar; 39(5):817-25. PubMed ID: 2310407
[TBL] [Abstract][Full Text] [Related]
18. Abnormal kinetic behavior of uroporphyrinogen decarboxylase obtained from rats with hexachlorobenzene-induced porphyria.
Chaufan G; Corvi MM; San Martín de Viale LC; Cárdenas ML; Ríos de Molina Mdel C
J Biochem Mol Toxicol; 2005; 19(1):19-24. PubMed ID: 15736160
[TBL] [Abstract][Full Text] [Related]
19. Genetic, iron status and sex factors of porphyria induced by hexachlorobenzene.
Smith AG; Stewart FP; Francis JE
IARC Sci Publ; 1986; (77):433-9. PubMed ID: 3596735
[TBL] [Abstract][Full Text] [Related]
20. Experimental hepatic porphyria caused by hexachlorobenzene: mechanism of the metabolic block.
De Matteis F
IARC Sci Publ; 1986; (77):427-31. PubMed ID: 3596734
[No Abstract] [Full Text] [Related]
[Next] [New Search]
